The aim of this study is to investigate the relationship between the expression levels of KIAA1199 in addition to HA, which could be detected by HA-binding protein (HABP) with immunostaining for osteosarcoma tissues, and their correlation with various clinical characteristics and patients’ prognosis. The gene discussed is HABP2; the disease is osteosarcoma.